分子Partners AG宣布与伯尔尼大学的研究合作，推动公司全资急性髓性白血病候选人，MP0533进入诊所的发展。
[分子伙伴AG]
[zotpress userid =“项目='nan'style ='apa'cite ='是']
标签档案：急性髓性白血病
Kat6a和EL形成表述转录控制模块，以驱动关键白血病基因表达程序
IDH-突变体AML细胞增强子DNA甲基化动力学的焦点破坏
成人患者的免疫抑制和结果德诺维急性髓性白血病，具有正常的核型
PVRIG是一种新型天然杀手细胞免疫检查点受体，急性髓性白血病
库拉肿瘤学提供了关于急性髓性白血病KO-539的IB阶段IB研究的更新
Kura oncology，Inc。announced that the US FDA has placed the KOMET-001 Phase Ib study of KO-539 in patients with relapsed or refractory acute myeloid leukemia on a partial clinical hold following the company’s recent report of a Grade 5 serious adverse event (patient death) potentially associated with differentiation syndrome.
[Kura oncology，Inc。]
[zotpress userid =“项目='nan'style ='apa'cite ='是']